APOE and Alzheimer disease: Changes in hippocampal volume serve as a sensitive and early biomarker of neurodegeneration in AD patients, and APOE ε4 is associated with atrophic hippocampal volume in AD (Liu et al., 2015) and MCI patients, but not in CN elders (Farlow et al., 2004; Morra et al., 2009).